Phase I/II study of LAG525 ± spartalizumab (PDR001) in patients with advanced malignancies

David Hong, Patrick Schöffski, Aitana Calvo, John Sarantopoulos, María Ochoa de Olza, Richard D Carvajal, Amy Prawira, Chrisann Kyi, Taito Esaki, Wallace Akerley, Filippo de Braud, Rina Hui, Tian Zhang, Ross Soo, Michela Maur, Andrew Weickhardt, Niladri Ro

American Society of Clinical Oncology 2018